You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 12, 2024

Roche Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ROCHE, and what generic and branded alternatives to ROCHE drugs are available?

ROCHE has sixty-one approved drugs.

Summary for Roche

US Patents:	0
Tradenames:	49
Ingredients:	45
NDAs:	61
Patent Litigation for Roche:	See patent lawsuits for Roche

Drugs and US Patents for Roche

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Roche	TAMIFLU	oseltamivir phosphate	FOR SUSPENSION;ORAL	021246-001	Dec 14, 2000		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Roche	AZO GANTRISIN	phenazopyridine hydrochloride; sulfisoxazole	TABLET;ORAL	019358-001	Aug 31, 1990		DISCN	Yes	No		⤷ Sign Up				⤷ Sign Up
Roche	RIMIFON	isoniazid	INJECTABLE;INJECTION	008420-003	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Roche	LARODOPA	levodopa	CAPSULE;ORAL	016912-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Roche	ENDEP	amitriptyline hydrochloride	CONCENTRATE;ORAL	085749-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No		⤷ Sign Up				⤷ Sign Up
Roche	ARFONAD	trimethaphan camsylate	INJECTABLE;INJECTION	008983-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Roche

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Roche	RIMADYL	carprofen	TABLET;ORAL	018550-003	Dec 31, 1987	3,896,145	⤷ Sign Up
Roche	BONIVA	ibandronate sodium	INJECTABLE;INTRAVENOUS	021858-001	Jan 6, 2006	5,662,918	⤷ Sign Up
Roche	KLONOPIN RAPIDLY DISINTEGRATING	clonazepam	TABLET, ORALLY DISINTEGRATING;ORAL	020813-005	Dec 23, 1997	4,371,516	⤷ Sign Up
Roche	TEGISON	etretinate	CAPSULE;ORAL	019369-002	Sep 30, 1986	4,200,647	⤷ Sign Up
Roche Palo	CELLCEPT	mycophenolate mofetil hydrochloride	INJECTABLE;INJECTION	050758-001	Aug 12, 1998	4,753,935	⤷ Sign Up
Roche Palo	FEMSTAT	butoconazole nitrate	SUPPOSITORY;VAGINAL	019359-001	Nov 25, 1985	4,078,071	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Paragraph IV (Patent) Challenges for ROCHE drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Capsule	75 mg	➤ Subscribe	2010-11-15
➤ Subscribe	Oral Suspension	6 mg/mL	➤ Subscribe	2015-06-18
➤ Subscribe	Injection	1 mg/mL, 1 mL vials	➤ Subscribe	2004-06-01
➤ Subscribe	Injection	1 mg/mL, 3 mL Vial	➤ Subscribe	2007-08-31
➤ Subscribe	For Oral Suspension	200 mg/mL	➤ Subscribe	2011-03-25
➤ Subscribe	Capsules	30 mg and 45 mg	➤ Subscribe	2011-08-02
➤ Subscribe	Injection	0.1 mg/mL, 1 mL single dose vial	➤ Subscribe	2007-03-08
➤ Subscribe	Injection	1 mg/mL, 4 mL multi-dose vials	➤ Subscribe	2004-07-19
➤ Subscribe	Tablets	2.5 mg and 150 mg	➤ Subscribe	2007-05-16

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.